Tadaichi Kitamura
Overview
Explore the profile of Tadaichi Kitamura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
1884
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Suzuki S, Sekizawa A, Tanaka M, Matsuda H, Okai T, Kinoshita K, et al.
Jpn J Infect Dis
. 2016 Feb;
69(4):347-9.
PMID: 26902221
No abstract available.
22.
Miyamori D, Ishikawa N, Idota N, Kakiuchi Y, McLean S, Kitamura T, et al.
Investig Genet
. 2016 Jan;
6:14.
PMID: 26719788
Background: According to the dual structure model, the modern Japanese ethnic population consists of a mixture of the Jomon people, who have existed in Japan since at least the New...
23.
Imai H, Nakao H, Shinohara H, Watarai M, Matsumoto N, Yamagishi T, et al.
PLoS One
. 2015 Jul;
10(7):e0132462.
PMID: 26176861
Background And Methods: We conducted a community-based study to evaluate genotype-specific prevalence of high-risk HPV (HR-HPV) and potential predictors of its presence in young, asymptomatic, female college students. Self-administered surveys...
24.
Onozawa M, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, Kitamura T, et al.
Jpn J Clin Oncol
. 2014 Aug;
44(10):969-81.
PMID: 25098707
Objective: The objective of the present study was to investigate the trends over time in the initial treatment of prostate cancer in Japan. Methods: A total of 8291 patients with...
25.
Maekawa S, Suzuki M, Arai T, Suzuki M, Kato M, Morikawa T, et al.
Int J Urol
. 2014 Jul;
21(12):1234-8.
PMID: 25040002
Objectives: To investigate the association between the TMPRSS2 Met160Val polymorphism and the risk of prostate cancer in Japanese men. Methods: Genomic DNA samples from 518 Japanese sporadic prostate cancer patients,...
26.
Nishimatsu H, Kitamura T, Yamada D, Nomiya A, Niimi A, Suzuki M, et al.
Aging Male
. 2014 May;
17(2):112-6.
PMID: 24844765
"LEOPIN ROYAL®" (LER), a non-prescription health-promoting medication in Japan, is a preparation containing six natural medicines, namely, aged garlic extract, ginseng, oriental bezoar, velvet antler, cuscuta seed and epimedium herb....
27.
Inamoto T, Azuma H, Hinotsu S, Tsukamoto T, Oya M, Ogawa O, et al.
J Cancer Res Clin Oncol
. 2014 Mar;
140(7):1197-204.
PMID: 24676427
Objectives: Primary androgen deprivation therapy (PADT) had been used extensively in Japan than in the USA and European countries regardless of the disease risk or patient's age. To illustrate the...
28.
Akaza H, Hinotsu S, Usami M, Ogawa O, Kitamura T, Suzuki K, et al.
Prostate Int
. 2013 Nov;
1(2):81-8.
PMID: 24223407
Purpose: To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an luteinizing hormone releasing hormone (LHRH) analog on overall survival of prostate cancer patients in...
29.
Mizumori O, Zembutsu H, Kato Y, Tsunoda T, Miya F, Morizono T, et al.
Exp Ther Med
. 2012 Sep;
1(6):955-961.
PMID: 22993625
Interleukin (IL)-2 and interferon (IFN)-α combination therapy for metastatic renal cell carcinoma (RCC) improves the prognosis for a subset of patients, while some patients suffer from severe adverse drug reactions...
30.
Suzuki M, Liu M, Kurosaki T, Suzuki M, Arai T, Sawabe M, et al.
Clin Genitourin Cancer
. 2011 Jun;
9(1):46-52.
PMID: 21700508
Unlabelled: We conducted present study to address whether the rs6983561 polymorphism, an established genetic marker for prostate cancer susceptibility, was a prognostic indicator. We genotyped 518 Japanese patients with prostate...